Clinical Trial Detail

NCT ID NCT02446704
Title Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

lung small cell carcinoma

Therapies

Olaparib

Temozolomide

Age Groups: adult

No variant requirements are available.